Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial

about

Efficacy and safety of weekly nab-paclitaxel plus cisplatin with concurrent intensity-modulated radiotherapy in patients with inoperable, locally advanced esophageal cancer: a pilot trial

Item

http://www.wikidata.org/entity/Q57490416

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@en

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@nl

type

Item

label

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@en

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@nl

prefLabel

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@en

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@nl

P1476

Efficacy and safety of weekly ...... ophageal cancer: a pilot trial

@en

P2093

Daquan Wang

http://www.w3.org/2001/XMLSchema#string

Dong Qian

http://www.w3.org/2001/XMLSchema#string

Hualei Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Wang

http://www.w3.org/2001/XMLSchema#string

Qingsong Pang

http://www.w3.org/2001/XMLSchema#string

Wencheng Zhang

http://www.w3.org/2001/XMLSchema#string

Xi Chen

http://www.w3.org/2001/XMLSchema#string

Yong Guan

http://www.w3.org/2001/XMLSchema#string

P2860

Evolving Evidence of the Efficacy and Safety of nab-Paclitaxel in the Treatment of Cancers with Squamous Histologies

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients

Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma

P304

6333-6338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S168275

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319273

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

6167982

http://www.w3.org/2001/XMLSchema#string